| Predicate |
Object |
| contentType |
Journal Article|Review|Research Support, Non-U.S. Gov't|Research Support, N.I.H., Extramural |
| endingPage |
1069 |
| issn |
1875-8908
1387-2877 |
| issueIdentifier |
4 |
| pageRange |
1049-1069 |
| publicationName |
Journal of Alzheimer's disease : JAD |
| startingPage |
1049 |
| hasFundingAgency |
http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_916de93fe8f49855f42e16db43537393 |
| isSupportedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_be81b2957ed30fe0ec53a9468e72f1cb
http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_fcd990787b26447e87cb433d9eeefeb2 |
| bibliographicCitation |
Kandimalla R, Reddy PH. Therapeutics of Neurotransmitters in Alzheimer's Disease. J Alzheimers Dis. 2017;57(4):1049–69. PMID: 28211810; PMCID: PMC5793221. |
| creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f073f173e82b7e7be22dd3d688aafbef
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_892f8dfb9b7a82df12e2750533ccd1a5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-3313-4393 |
| date |
2017-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| identifier |
https://doi.org/10.3233/jad-161118
https://pubmed.ncbi.nlm.nih.gov/PMC5793221
https://pubmed.ncbi.nlm.nih.gov/28211810 |
| isPartOf |
https://portal.issn.org/resource/ISSN/1875-8908
https://portal.issn.org/resource/ISSN/1387-2877
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 |
| language |
English |
| source |
https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/ |
| title |
Therapeutics of Neurotransmitters in Alzheimer’s Disease |
| discusses |
http://id.nlm.nih.gov/mesh/M0027603 |
| discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10721
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11385
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6860
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 |